Skip to main content
Walvax Biotechnology Co.,Ltd. logo

Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300142 ISIN · CNE100000WN2 LEI · 300300H82R2DIQXA8N24 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,790 across all filing types
Latest filing 2022-09-27 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300142

About Walvax Biotechnology Co.,Ltd.

https://www.walvax.com

Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.

Recent filings

Filing Released Lang Actions
独立董事提名人声明（曾令冰）
Board/Management Information Classification · 100% confidence The document is a public statement from the board of directors nominating an individual as an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with relevant laws and regulations, and independence criteria. There is no financial data, earnings information, or report publication mentioned. The content is focused on board/management information, specifically about a nomination for a board position. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is sufficient and the content is substantive, not a mere announcement or certification.
2022-09-27 Chinese
独立董事候选人声明（孙钢宏）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of a company, detailing compliance with various legal and regulatory requirements for serving as an independent director. It includes statements about qualifications, independence, and adherence to relevant laws and regulations. There is no financial data, no mention of financial results, no discussion of company performance, and no indication of a report or announcement of voting results. The content is related to board/management information, specifically about a candidate for the board of directors. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length (5811 characters) and detailed statements support this classification with high confidence.
2022-09-27 Chinese
独立董事候选人声明（曾令冰）
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of a company, stating compliance with various legal and regulatory requirements for serving as an independent director. It includes multiple attestations about qualifications, independence, and adherence to relevant laws and regulations. There is no financial data, no discussion of company performance, no voting results, no meeting materials, and no mention of report publication. The document is a formal declaration related to board/management information, specifically about a candidate for the board of directors. Therefore, it fits best under the category of Board/Management Information (MANG). The document length (5757 characters) supports it being a full declaration rather than a brief announcement or certification.
2022-09-27 Chinese
关于回购公司股份实施结果暨股份变动的公告
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement about the completion of a share repurchase program by the company Yunnan Watson Biotechnology Co., Ltd. It includes specifics on the number of shares repurchased, prices, compliance with regulatory rules, and the intended use of the repurchased shares for employee stock ownership or equity incentive plans. The document does not contain financial statements or quarterly/yearly financial results but focuses on the share buyback activity and related disclosures. This matches the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback of its own shares.
2022-09-16 Chinese
关于开设募集资金专用账户并签订募集资金监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the opening of a special account for raised funds and the signing of a supervision agreement related to the use of those funds. It details the parties involved, the purpose of the account, and the supervisory responsibilities. There are no financial statements, no quarterly or annual results, no management discussion of financial performance, nor is it a transcript or presentation. The document is relatively short (1828 characters) and serves as a formal notification about fundraising fund management and regulatory compliance. This fits the definition of a Capital/Financing Update (CAP) as it relates to fundraising activities and capital management.
2022-09-16 Chinese
关于完成工商变更登记的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from a company about the completion of a business registration change, specifically regarding an increase in registered capital and amendments to the company charter. It references board and shareholder meetings approving these changes and states that the company has completed the registration with the market supervision bureau. The document is short (955 characters) and primarily serves as a formal notice of the completion of capital and charter changes, not a detailed financial report or presentation. This fits the category of Share Issue/Capital Change announcements, which cover new share issues or capital changes.
2022-09-15 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.